This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medgenics Mourns The Loss Of Board Member Gary Brukardt

Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of Biopump™, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces the passing of Director Gary Brukardt on Tuesday, August 21, 2012. Mr. Brukardt, age 66, had served on the Company’s Board of Directors since 2006 and was a member of the Audit Committee and the Nominating and Corporate Governance Committee.

"We are deeply saddened by the sudden and untimely passing of Gary Brukardt, our esteemed colleague and friend. Gary was dedicated to the success of Medgenics and his insight, energy and judgment as a Director made him an integral part of our leadership team,” stated Andrew L. Pearlman, Ph.D., President and Chief Executive Officer of Medgenics. “On behalf of the Board of Directors and all of Medgenics, we offer our condolences to his family. Our thoughts and sympathies are with them at this difficult time."

Mr. Brukardt had more than 30 years of experience in the healthcare industry. He was a founder of SpecialtyCare and served as its Chairman and CEO until his passing. Under his leadership SpecialtyCare became the premier provider of outsourced clinical services, supporting 322,000 surgical procedures annually at more than 760 hospitals.

Previously he was EVP and COO of Renal Care Group, after which time he served as its President and CEO. Renal Care Group provided dialysis services to more than 32,500 patients at more than 450 outpatient dialysis facilities. Mr. Brukardt led Renal Care Group’s $3.5 billion acquisition by Fresenius Medical Care in March 2006, which resulted in the creation of the world’s largest integrated provider of dialysis services.

Earlier in his career he was EVP of Baptist Health Care Affiliates while also serving as Chairman of HealthNet Management, Inc., a managed care services company.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs